FindTrial
Sign In

Gut microbiota intervention influence the efficacy of tumor immunotherapy (observational study)

Gut microbiota intervention influence the efficacy of tumor immunotherapy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047045
Enrollment
Unknown
Registered
2021-06-07
Start date
2021-06-06
Completion date
Unknown
Last updated
2022-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer

Interventions

Case group:None

Sponsors

The Tenth People' s Hospital, Medical School of Tongji University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 16 years; 2. Gender is not limited; 3. Cancer patients receiving car-t or PD-1 / PD-L1 inhibitors for any reason.

Exclusion criteria

Exclusion criteria: No evaluation of efficacy for any reason.

Design outcomes

Primary

MeasureTime frame
Gut microbiome;Tumor efficacy related indicators;—

Secondary

MeasureTime frame
Immune status;Side effects of cancer treatment;—

Countries

China

Contacts

Public ContactLi Ning

The Tenth People's Hospital, Medical School of Tongji University

liningrigsnju@163.com+86 2166302161

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026